東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Pharmaceutical pricing and research ...

Gladin, Chris.

FindBook

Google Book

Amazon

博客來

Pharmaceutical pricing and research and development investment: A secondary analysis that investigates product and patent output.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Pharmaceutical pricing and research and development investment: A secondary analysis that investigates product and patent output./
作者:	Gladin, Chris.
面頁冊數:	88 p.
附註:	Source: Dissertation Abstracts International, Volume: 67-10, Section: A, page: 3887.
Contained By:	Dissertation Abstracts International67-10A.
標題:	Business Administration, Management. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3238563
ISBN:	9780542933547

Pharmaceutical pricing and research and development investment: A secondary analysis that investigates product and patent output.
Gladin, Chris.

Pharmaceutical pricing and research and development investment: A secondary analysis that investigates product and patent output. - 88 p.

Source: Dissertation Abstracts International, Volume: 67-10, Section: A, page: 3887.

Thesis (Ph.D.)--Capella University, 2006.

The purpose of this study is to examine the various types of international drug price regulation and how that regulation impacts R&D expenditure in specific countries. Conversely, do R&D expenditures ultimately dictate pricing levels within select countries; that is, does a country that has lower R&D investment equate to lower drug prices. This study used a descriptive design that focused on the present condition. The descriptive method includes empirical observation through the use of secondary data analysis on the current conditions. This method was utilized to determine the functional relationship and significant effect of pharmaceutical pricing regulation to R&D investment resulting in decreased product and patent output.

ISBN: 9780542933547Subjects--Topical Terms:

626628
Business Administration, Management.

Pharmaceutical pricing and research and development investment: A secondary analysis that investigates product and patent output.
LDR:01686nmm 2200289 4500 001 1832418
005 20070625074213.5
008 130610s2006 eng d
020 $a 9780542933547
035 $a (UnM)AAI3238563
035 $a AAI3238563
040 $a UnM $c UnM
100 1 $a Gladin, Chris. $3 1921145
245 1 0 $a Pharmaceutical pricing and research and development investment: A secondary analysis that investigates product and patent output.
300 $a 88 p.
500 $a Source: Dissertation Abstracts International, Volume: 67-10, Section: A, page: 3887.
500 $a Adviser: John Machnic.
502 $a Thesis (Ph.D.)--Capella University, 2006.
520 $a The purpose of this study is to examine the various types of international drug price regulation and how that regulation impacts R&D expenditure in specific countries. Conversely, do R&D expenditures ultimately dictate pricing levels within select countries; that is, does a country that has lower R&D investment equate to lower drug prices. This study used a descriptive design that focused on the present condition. The descriptive method includes empirical observation through the use of secondary data analysis on the current conditions. This method was utilized to determine the functional relationship and significant effect of pharmaceutical pricing regulation to R&D investment resulting in decreased product and patent output.
590 $a School code: 1351.
650 4 $a Business Administration, Management. $3 626628
650 4 $a Health Sciences, Pharmacy. $3 1017737
650 4 $a Health Sciences, Health Care Management. $3 1017922
690 $a 0454
690 $a 0572
690 $a 0769
710 2 0 $a Capella University. $3 1017687
773 0 $t Dissertation Abstracts International $g 67-10A.
790 1 0 $a Machnic, John, $e advisor
790 $a 1351
791 $a Ph.D.
792 $a 2006
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=3238563